325 related articles for article (PubMed ID: 10225361)
1. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.
Sakurada T; Yogo H; Manome Y; Tan-No K; Sakurada S; Yamada A; Kisara K; Ohba M
Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):387-92. PubMed ID: 7531295
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antagonistic effects of sendide and CP-96,345 on a spinally mediated behavioural response in mice.
Sakurada T; Manome Y; Katsumata K; Tan-No K; Sakurada S; Ohba M; Kisara K
Eur J Pharmacol; 1994 Aug; 261(1-2):85-90. PubMed ID: 7528145
[TBL] [Abstract][Full Text] [Related]
4. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.
Sakurada T; Katsuyama S; Sakurada S; Inoue M; Tan-No K; Kisara K; Sakurada C; Ueda H; Sasaki J
Br J Pharmacol; 1999 Aug; 127(7):1712-8. PubMed ID: 10455330
[TBL] [Abstract][Full Text] [Related]
5. Naloxone-reversible effect of spantide on the spinally mediated behavioural response induced by neurokinin-2 and -3 receptor agonists.
Sakurada T; Manome Y; Katsumata K; Uchiumi H; Tan-No K; Sakurada S; Kisara K
Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):69-75. PubMed ID: 1383832
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological profile of sendide, a tachykinin NK-1 receptor antagonist].
Kisara K; Tan-No K; Sakurada T
Nihon Yakurigaku Zasshi; 1997 Dec; 110(6):315-24. PubMed ID: 9503389
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors.
Sakurada S; Orito T; Furuta S; Watanabe H; Mobarakeh JI; Yanai K; Watanabe T; Sato T; Onodera K; Sakurada C; Sakurada T
Pharmacol Biochem Behav; 2003 Jan; 74(2):487-93. PubMed ID: 12479971
[TBL] [Abstract][Full Text] [Related]
8. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
9. A selective and extremely potent antagonist of the neurokinin-1 receptor.
Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K; Ohba M; Terenius L
Brain Res; 1992 Oct; 593(2):319-22. PubMed ID: 1280526
[TBL] [Abstract][Full Text] [Related]
10. The neurokinin-1 receptor antagonist, sendide, exhibits antinociceptive activity in the formalin test.
Sakurada T; Katsumata K; Yogo H; Tan-No K; Sakurada S; Ohba M; Kisara K
Pain; 1995 Feb; 60(2):175-180. PubMed ID: 7540280
[TBL] [Abstract][Full Text] [Related]
11. Differential antinociceptive effects of sendide, a NK1-receptor antagonist, and morphine in the capsaicin test.
Sakurada T; Yogo H; Katsumata K; Tan-No K; Sakurada S; Kisara K; Ohba M
Brain Res; 1994 Jun; 649(1-2):319-22. PubMed ID: 7525010
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
Ahluwalia A; Giuliani S; Maggi CA
Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
[TBL] [Abstract][Full Text] [Related]
13. Involvement of tachykinin NK1 receptors in nociceptin-induced hyperalgesia in mice.
Sakurada C; Sakurada S; Katsuyama S; Sasaki J; Tan-No K; Sakurada T
Brain Res; 1999 Sep; 841(1-2):85-92. PubMed ID: 10546991
[TBL] [Abstract][Full Text] [Related]
14. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
16. Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.
Piot O; Betschart J; Grall I; Ravard S; Garret C; Blanchard JC
Br J Pharmacol; 1995 Nov; 116(5):2496-502. PubMed ID: 8581290
[TBL] [Abstract][Full Text] [Related]
17. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
18. N-terminal substance P fragments inhibit the spinally induced, NK 1 receptor mediated behavioural responses in mice.
Sakurada T; Tan-No K; Yamada T; Sakurada S; Kisara K; Ohba M; Terenius L
Life Sci; 1990; 47(20):PL109-13. PubMed ID: 1701844
[TBL] [Abstract][Full Text] [Related]
19. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
20. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
